BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15529390)

  • 1. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
    Reuman PD
    Arthritis Rheum; 2004 Nov; 50(11):3616-8. PubMed ID: 15529390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma.
    Funauchi M; Ikoma S; Enomoto H; Sugiyama M; Ohno M; Hamada K; Kanamaru A
    Clin Exp Rheumatol; 1998; 16(4):479-82. PubMed ID: 9706433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactorrhea in a 14-year-old girl.
    Panamonta O; Pakawut N
    J Med Assoc Thai; 2006 Aug; 89(8):1304-7. PubMed ID: 17048445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
    McMurray RW; Weidensaul D; Allen SH; Walker SE
    J Rheumatol; 1995 Nov; 22(11):2084-91. PubMed ID: 8596149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?
    Li M; Keiser HD; Peeva E
    Clin Rheumatol; 2006 Jul; 25(4):602-5. PubMed ID: 16404500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
    Zhang LN; Shi TY; Yang YJ; Zhang FC
    Lupus; 2014 Apr; 23(4):417-20. PubMed ID: 24446305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
    Oshige T; Nakamura Y; Sasaki Y; Kawano S; Ohki T; Tsuruta M; Tokubuchi I; Nakayama H; Yamada K; Ashida K; Tajiri Y; Nomura M
    Intern Med; 2019 Nov; 58(21):3125-3128. PubMed ID: 31243214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis and prolactinoma.
    Kararizou E; Stamboulis E; Markou I; Alevizaki M; Gkiatas K
    Funct Neurol; 2007; 22(1):39-41. PubMed ID: 17509242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive pituitary surgery in a hemorrhagic necrosis of adenoma during pregnancy.
    Gondim J; Ramos Júnior F; Pinheiro I; Schops M; Tella Júnior OI
    Minim Invasive Neurosurg; 2003 Jun; 46(3):173-6. PubMed ID: 12872196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy in a patient with prolactinoma off treatment.
    Sood A; Kalra S; Gulati MS; Mittal S
    J Assoc Physicians India; 2000 Dec; 48(12):1221. PubMed ID: 11280238
    [No Abstract]   [Full Text] [Related]  

  • 13. Demographic characteristics, presentations and treatment outcome of patients with prolactinoma.
    Malik S; Hussain SZ; Basit R; Idress N; Habib A; Zamant M; Islam N
    J Ayub Med Coll Abbottabad; 2014; 26(3):269-74. PubMed ID: 25671924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy].
    Nakajima T; Tamura T; Kuroki M; Tanaka R; Hayashi H
    No Shinkei Geka; 1992 Oct; 20(10):1091-5. PubMed ID: 1407345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactinoma as a cause of primary amenorrhea in a 16-year-old girl].
    Beń-Skowronek I; Szewczyk L; Witkowski D
    Ginekol Pol; 1999 May; 70(5):367-9. PubMed ID: 10462983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal epidural lipomatosis associated with pituitary macroprolactinoma.
    Fujisawa H; Hasegawa M; Tachibana O; Yamashita J
    Acta Neurochir (Wien); 2002 Feb; 144(2):213-4. PubMed ID: 11862525
    [No Abstract]   [Full Text] [Related]  

  • 17. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 18. [Do articular manifestations appear in prolactinomas?].
    Bauduceau B; Eulry F; Mayaudon H; Ducorps M; Helie C; Riveline JP
    Presse Med; 1995 Apr; 24(14):695. PubMed ID: 7770420
    [No Abstract]   [Full Text] [Related]  

  • 19. Pituitary prolactinoma associated with polycystic ovary--case report.
    Kuroda S; Yonekawa Y; Kawano T
    Neurol Med Chir (Tokyo); 1991 Nov; 31(11):736-9. PubMed ID: 1723164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-secreting macroadenoma in a prepubertal girl.
    Kashiwagi S; Nishizaki T; Harada K; Ito H; Setoguchi M; Takahashi M; Ishihara T
    Childs Nerv Syst; 1998 Oct; 14(10):602-5. PubMed ID: 9840387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.